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ttp://dx.doi.org/10.1016/j.ajpath.2014.05.014Angiotensin II (Ang II) promotes development of ascending aortic aneurysms (AAs), but progression of
this pathology is undeﬁned. We evaluated factors potentially involved in progression, and determined
the temporal sequence of tissue changes during development of Ang IIeinduced ascending AAs. Ang II
infusion into C57BL/6J mice promoted rapid expansion of the ascending aorta, with signiﬁcant in-
creases within 5 days, as determined by both in vivo ultrasonography and ex vivo sequential acquisition
of tissues. Rates of expansion were not signiﬁcantly different in LDL receptorenull mice fed a saturated
fat-enriched diet, demonstrating a lack of effect of hypercholesterolemia. Augmenting systolic blood
pressure with norepinephrine infusion had no signiﬁcant effect on ascending aortic expansion. Path-
ological changes observed within 5 days of Ang II infusion included increased medial thickness and
intramural hemorrhage characterized by erythrocyte extravasation in outer lamellar layers of the media.
Intramedial hemorrhage was not observed after prolonged Ang II infusion, although partial medial
disruption was present. Elastin fragmentation and transmural medial breaks of the ascending aorta were
observed with continued Ang II infusion, which were restricted to anterior aspects. CD45þ cells
accumulated in adventitia but were minimal in media. Similar pathology was observed in tissues ob-
tained from patients with ascending AAs. In conclusion, Ang II promotes ascending AAs through
region-speciﬁc changes that are independent of hypercholesterolemia or systolic blood pressure.
(Am J Pathol 2014, 184: 2586e2595; http://dx.doi.org/10.1016/j.ajpath.2014.05.014)Supported by NIH grants R01-HL107319 (A.D.) and P20-GM103527
(L.A.C.) and a Sarnoff Cardiovascular Foundation Fellowship (F.M.D.).
Disclosures: None declared.The renineangiotensin system has been invoked as a major
mediator of experimental thoracic aortic aneurysms (AAs).1,2
Pivotal studies inferring a role for the renineangiotensin
system in thoracic aortic aneurysms demonstrated that an
AT1 receptor antagonist, losartan, ablated ascending aorta
dilation in mice expressing a C1039G mutation of ﬁbrillin-1,
or functionally compromised mutations of transforming
growth factor-b receptor.3,4 AT1 receptor antagonism also
attenuated ascending aortic dilation induced by transverse
aortic constriction.5 Conversely, infusion of pressor doses of
Ang II promoted formation of pathology in the ascending
aorta that included pronounced dilation and rupture in the
ascending aorta.6e9
In accord with experimental data, a role for the renine
angiotensin system has also been invoked in development of
human ascending AAs. Initial evidence came from a retro-
spective analysis demonstrating that administration of anstigative Pathology.
.AT1 receptor antagonist attenuates ascending aorta dilation
in individuals with Marfan syndrome.10 This seminal
observation contributed to initiation of multiple clinical
trials to determine efﬁcacy of AT1 receptor antagonism in a
range of patients with ascending AAs, including those with
Marfan syndrome or bicuspid aortic valves.11
Although Ang II is evolving as a signiﬁcant risk factor for
development of ascending AAs, there remain many unre-
solved issues regarding the mechanism by which this pa-
thology is formed, including interaction of commonly
assumed risk factors such as elevated blood pressure and
plasma cholesterol concentrations.12 Although these are
common considerations in the therapeutic approach to
Ang II and Ascending Aortic Aneurysmindividuals with ascending AAs, evidence supporting a
causal role in ascending AAs is modest.12 In addition, the
natural evolution of ascending AAs remains largely unde-
ﬁned, which greatly hinders interpretation of mechanistic
insights.
Ang II infusion into mice promotes a reproducible model
of ascending AAs that may provide insight into the human
disease.7,9,13 We used both in vivo and ex vivo techniques in
this model to determine contributions of plasma cholesterol
concentrations and blood pressure to the development of
ascending AAs. Having established conditions for gener-
ating Ang IIeinduced ascending AAs, we then examined
the sequence of pathological changes in the evolution of
Ang IIeinduced ascending AAs, to provide mechanistic
insight into the localization of the aortic pathology.
Materials and Methods
Mice and Diet
Male C57BL/6J and LDL receptorenull mice (strain
B6.129S7-Ldlrtm1Her/J; hereafter, Ldlr/) were purchased
from the Jackson Laboratory (Bar Harbor, ME; stock number
000664 and 002207, respectively). Mice were housed in
individually ventilated cages with negative air pressure
(Allentown, Inc., Allentown, NJ), ﬁve mice per cage. Aspen
hardwood chips (Sani-Chip, 7090A; Harlan Laboratories,
Madison, WI) were used as bedding. Drinking water was
ﬁltered by reverse osmosis (pH 6.0 to 6.2). The lighting cycle
in the room was 14 hours of light and 10 hours of dark.
Ambient temperature ranged from 20C to 23.3C (68F to
74F); relative humidity was 50% to 60%. All mice were 8
weeks old at the start of study. C57BL/6J mice were fed a
normal laboratory diet (2918 Harlan Teklad Global 18%
protein rodent diet; Harlan Laboratories). Ldlr/ mice were
fed a saturated fateenriched diet containing 21% w/w milk
fat and 0.2% w/w cholesterol (Harlan Teklad TD.88137;
Harlan Laboratories) beginning 1 week before and
continuing throughout Ang II infusion. Mice were observed
daily and weighed weekly. Necropsy was performed to
determine cause of any death during Ang II infusion. All
procedures were approved by the University of Kentucky
Institutional Animal Care and Use Committee.
Ultrasonic Imaging
The ascending aorta was imaged using a Vevo 2100 ultra-
sound system with a MicroScan MS400 transducer (18 to 38
MHz, resolution 30 mm; VisualSonics, Toronto, ON, Can-
ada).14 Mice were anesthetized using isoﬂurane (Isothesia;
Butler Animal Health Supply, Dublin, OH), and hair was
removed from the chest using hair clippers and depilatory
cream (Nair; Church and Dwight Co., Princeton, NJ). Ul-
trasonic gel (Medline, Mundelein, IL) was placed on the
shaved area, and a transducer was used for imaging. An
example of a B-mode ultrasonic image is shown inThe American Journal of Pathology - ajp.amjpathol.orgSupplemental Figure S1. M-mode ultrasonic images to track
vessel wall motion were obtained on the ascending aorta,
0.5 mm proximal to the innominate artery.
Strain Quantiﬁcation and Vessel Stiffness
A Vevo 2100 ultrasound system (VisualSonics) was used to
measure anterior wall motion (da), posterior wall motion
(dp), systolic diameter (Ds), and diastolic diameter (Dd). M-
mode measurements were acquired over three cardiac cy-
cles. These measurements were used, with the assumption
of uniform strain around the vessel, to calculate the
circumferential component of the GreeneLagrange strain
tensor and vessel stiffness.
Infusions
Ang II was infused via subcutaneous pumps as described
previously.15 Osmotic minipumps (Alzet model 2004;
Durect, Cupertino, CA) were ﬁlled with saline, 1000 ng/kg
per minute Ang II dissolved in saline, or 5.6 mg/kg per day
norepinephrine (NE) dissolved in saline containing 0.2%
ascorbic acid.16 Mice were sedated with a single 90/10 mg/kg
i.p. injection of ketamine/xylazine [Ketathesia (Butler Ani-
mal Health Supply, Dublin, OH)/AnaSed (Lloyd, She-
nandoah, IA)] or inhalant isoﬂurane (Isothesia; Butler
Animal Health Supply), and pumps were implanted subcu-
taneously on the right side of the mice. Surgical staples
(427631; BD Medical, Sparks, MD) were used to close the
incision site and a topical anesthetic cream (LMX4; Ferndale
Laboratories, Ferndale, MI) was applied.
Systolic Blood Pressure Measurements
A noninvasive tail-cuff system (Kent Scientiﬁc, Torrington,
CT) was used to measure systolic blood pressure at week 1
for baseline and during week 3 of infusion. Conscious mice
were restrained on a heated platform. Blood pressure was
measured at the same time each day for at least three
consecutive days. Criteria for acceptable data were acqui-
sition of at least 10 of 20 measurements (50%) and
SD <30 for each session.17
Serum Measurements
Blood was harvested by cardiac puncture, and serum was
separated by centrifugation. Total serum cholesterol con-
centrations were measured enzymatically according to the
manufacturer’s instructions (Cholesterol E, 439-17501;
Wako Chemicals USA, Richmond, VA).
Pathology
At selected intervals, mice were anesthetized with ketamine/
xylazine (90/10 mg/kg i.p.). Blood was collected by cardiac
puncture, and the aorta was ﬂushed with saline. Mice were2587
Rateri et alperfusion-ﬁxed at approximately 70 mmHg with formalin
in vivo, and the aorta was dissected free along with the heart.
Tissues were immersion-ﬁxed overnight. Extraneous tissue
was removed, and the ascending aorta was photographed.
The heart was then removed, and the aorta was opened,
pinned, photographed, and measured with Image-Pro soft-
ware version 7.0 (Media Cybernetics, Bethesda, MD). Prox-
imal thoracic aortic area was deﬁned as the ascending aorta to
3mmdistal to the subclavian arterial branch of the descending
aorta. It also includes 1 mm of the innominate and left com-
mon carotid branches. Aortic arch area (aortic root to left
subclavian arterial branch) was also measured (Supplemental
Figure S2). Diameters measured ex vivowere calculated from
the circumference of the proximal ascending aorta.
Ascending aortas were placed in Tissue-Tek OCT optimal
cutting temperature compound (Sakura Finetek Japan,
Tokyo, Japan; Sakura Finetek, Torrence, CA) and were
serially sectioned at 10 mm thickness (series of 10 slides with
nine sections per slide). Hematoxylin and eosin, Movat’s
pentachrome (k042; Poly Scientiﬁc R&D, Bay Shore, NY),
and Prussian Blue (cy005; Poly Scientiﬁc R&D) histological
stains were used to examine cellularity, elastin ﬁber integrity,
and iron, respectively. Immunostaining was performed to
detect speciﬁc cell types. The following antibodies were
used: a-actin for smooth muscle cells (ab5694; Abcam,
Cambridge, MA), CD45 for common leukocyte antigen (BD
Pharmingen clone 30-F11; 553077; BD Biosciences, San
Jose, CA), and reticular ﬁbroblasts and ﬁbers (clone ER-TR7;
ab51824; Abcam). Reactivity was determined using biotin-
labeled secondary antibodies (BA-4001 and BA-6000;
Vector Laboratories, Burlingame, CA), horseradish peroxi-
dase ABC kits (Peroxidase Elite Standard; PK-6100; Vector
Laboratories), and 3-amino-9-ethylcarbazole for chromogen
[ImmPACT AEC peroxidase (HRP) substrate; SK-4205;
Vector Laboratories]. Nonimmune primary antibodies, sec-
ondary only, and no primary or secondary antibody slides
were run as negative controls to conﬁrm speciﬁcity of pri-
mary antibodies, speciﬁcity of secondary antibodies, and
ablation of endogenous tissue peroxidase, respectively. For
medial thickness, the aortic media was measured from the
internal to the external elastic lamina of each section. Regions
with ulceration were excluded from these analyses. Elastin
breaks were counted on each section. These data were
collected on at least eight sections per mouse.
Human Thoracic Aneurysm Tissue
Surgical samples resected from patients with bicuspid aortic
valveeassociated ascending AAs were collected within 1
hour of resection and ﬂash-frozen in liquid nitrogen (Dr. John
Alex Elefteriades, Yale University, New Haven, CT). Spec-
imens were trimmed, immersed in optimal cutting tempera-
ture compound, and serially sectioned at 10 mm thickness
(series of 10 slides, with four sections per slide) using a
cryostat. Tissue sections were stained for elastin and collagen
using Movat’s pentachrome method. Antibodies were2588incubated with tissues to detect leukocytes (CD45, 0.5 mg/
mL; 555480; BD Biosciences, San Jose, CA) and smooth
muscle cells (a-actin, 2 mg/mL; ab5694; Abcam). Reactivity
of the antibodies with tissue antigens was detected using red
chromogen, 3-amino-9-ethylcarbazole [ImmPACT AEC
peroxidase (HRP) substrate; SK-4205; Vector Labora-
tories].18 All procedures were approved by the University of
Kentucky Institutional Review Board.
Statistical Analysis
Statistical tests included standard parametric procedures for
both a single response and repeated measures. Analyses
were performed predominantly using SigmaPlot software
version 12 (Systat Software, San Jose, CA). For ultrasound
data, a linear mixed model was used, expressing the mean
level of the outcome as a quadratic (diameter) or cubic (area,
strain) function of time within each group and including
random effects to account for correlations among repeated
measurements on the same mouse. Bonferroni adjustment
for post hoc testing was used to ascertain group differences
using all available observations. Ultrasound analyses used
SAS software version 9.3 (SAS Institute, Cary, NC). The
speciﬁc tests used are identiﬁed in the ﬁgure captions. Data
are represented as individual observations or as means
 SEM. P < 0.05 was considered statistically signiﬁcant.
Results
Noninvasive Imaging Conﬁrms Rapid Dilation of the
Ascending Aorta during Ang II Infusion
Saline- or Ang IIeinfused C57BL/6J mice were sequentially
imaged by ultrasound for 28 days. Aortic diameter and
luminal area of the ascending aorta were measured at multiple
intervals during infusion. Examples of ultrasonic images at
baseline and after 28 days of Ang II infusion are presented in
Figure 1. Signiﬁcant increases in diameter and luminal area
of the aortic arch were detected within 4 days of Ang II
infusion (P < 0.001) (Figure 1, C and D). Noninvasive
M-mode ultrasonic images were used to monitor changes in
vessel properties during Ang II infusion (Supplemental
Figure S3A). Vessel wall stiffness in the ascending aorta
was increased markedly by day 21 (P< 0.05) (Supplemental
Figure S3B). In addition, circumferential cyclic Greene
Lagrange strain, a mechanical characteristic of vessel
loading, progressively declined throughout the initial days of
Ang II infusion and was signiﬁcantly decreased by day 7
(P < 0.05) (Supplemental Figure S3C).
Ascending Aortic Area Expands Rapidly during Ang II
Infusion, Independent of Hypercholesterolemia and
Blood Pressure
To determine effects of hypercholesterolemia on Ang IIe
induced ascending AAs, male C57BL/6J (WT) mice wereajp.amjpathol.org - The American Journal of Pathology
Figure 2 Progressive dilation of Ang IIeinfused ascending AAs was
independent of hypercholesterolemia. A: Ang II infusion promoted pro-
gressive expansion of ascending aorta diameter in both normocholester-
olemic WT mice and hypercholesterolemic Ldlr/ mice. B: Intimal area of
proximal thoracic aorta. C: Intimal area of the aortic arch. Data are
expressed as means  SEM (AeC) and also as individual data points (A).
n Z 16 (WT) or 15 or 16 (Ldlr/) mice per time point. *P < 0.05, day 5
versus day 15 (B); day 0 versus day 5, day 5 versus 15, and day 15 versus
day 28 (C). ***P < 0.001, day 0 versus 28 (A); day 0 versus days 5, 15, and
28, day 5 versus day 28, and day 15 versus day 28 (B); and day 0 versus
days 15 and 28 and day 5 versus day 28 (C). Two-way analysis of variance
followed by the HolmeSidák test for multiple comparisons. Black symbols,
WT; white symbols, Ldlr/.
Figure 1 Rapid ascending aorta expansion is detected in vivo using
ultrasound. AeD: Aortas from saline-infused (white symbols) or
Ang IIeinfused (black symbols) C57BL/6J mice were measured by ultra-
sonic imaging at frequent intervals over 28 days. Shown are representative
ultrasonographic images of an aortic arch from an Ang IIeinfused mouse at
baseline (A) and at the end of infusion (B). C and D: Aortic diameter (C)
and luminal area (D) during infusion. Data are expressed as means  SEM.
n Z 5 mice per group. ***P < 0.001, Ang II versus saline. Two-way
repeated measures analysis of variance followed by the HolmeSidák test
for multiple comparisons.
Ang II and Ascending Aortic Aneurysmfed a normal laboratory diet, and male Ldlr/ mice were
fed a saturated fat-enriched diet. Groups of mice (nZ 15 to
16 per time point) were sacriﬁced at selected intervals (0, 5,
15, and 28 days) during Ang II infusion (1000 ng/kg per
minute). As expected, serum cholesterol concentrations
were signiﬁcantly elevated in Ldlr/ mice (112  7 versus
1439  288 mg/dL for WT versus Ldlr/; P < 0.001). In
Ang IIeinfused mice at 28 days, the ex vivo diameter of the
ascending aorta was dilated signiﬁcantly, compared with
saline-infused mice (P < 0.001) (Figure 2A); however, there
was no signiﬁcant difference between genotypes. Intimal
area of the proximal thoracic aorta from WT and Ldlr/
mice expanded during Ang II infusion at a rate that did not
differ statistically at any time point. By day 5 of Ang II
infusion, proximal thoracic aortic intimal area had increased
signiﬁcantly from day 0 in both groups (WT, 19.0  0.4 toThe American Journal of Pathology - ajp.amjpathol.org21.8  0.5 mm2; Ldlr/, 19.3  0.4 to 22.0  0.5 mm2;
P < 0.001) (Figure 2B). Aortic expansion continued during
the 28-day infusion period, with proximal thoracic aortic
area of WT and Ldlr/ groups increasing 33% and 28%,
respectively, compared with baseline (P < 0.001). This
measurement has been used previously,7,9,13 but because it
includes part of the descending thoracic aorta in addition to
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Figure 3 Ang IIeinduced ascending aortic expansion is independent of
systolic blood pressure. A: Systolic blood pressures measured during the
last week of infusion. B: Intimal area. Data are expressed as means  SEM
(A and B) and also as individual data points (B). nZ 9 (saline) or nZ 10
(Ang II and NE). *P < 0.05, saline versus Ang II and NE; ***P < 0.001,
Ang II versus saline and NE. One-way analysis of variance followed by the
HolmeSidák test for multiple comparisons.
Figure 4 Interlamellar hemorrhage, located on the anterior portion of
the ascending aorta, is an early pathological manifestation during Ang II
infusion. AeC: Representative images of intact saline-infused (A) and
Ang IIeinfused (B) aortic arch and of en face Ang IIeinfused aortic arch
(C) in male C57BL/6J mice. Location of hemorrhage is indicated by an
asterisk. DeI: Representative images of ascending aortic cross sections of
Ang IIeinfused mice at day 0 and day 5 of Ang IIeinfused stained with
hematoxylin and eosin (D and E), stained with Movat’s pentachrome (F and G),
and immunostained for smooth muscle a-actin (H and I, red). Location of
medial erythrocytes is indicated by an asterisk. Images are oriented with
lumen at top and adventitia at bottom. H&E, hematoxylin and eosin.
Rateri et almodiﬁed measurements of the intimal area to include only
the aortic arch. In both genotypes, the aortic arch had
expanded signiﬁcantly by day 5 (PZ 0.013) and continued
to increase in area during the 28 days of Ang II infusion
(WT, 9.8  0.3 to 14.2  0.6; Ldlr/, 10.1  0.2 to
13.5  0.5; P < 0.001) (Figure 2C).
Concomitantwith intimal area expansionwere pathological
changes in themedia of the ascending aorta during the 28 days
ofAng II infusion.Medial thickness increased signiﬁcantly by
day 5 of Ang II infusion; however, elastin fragmentation was
not signiﬁcant until day 28 (Supplemental Figure S4, A and
B). Irrespective of the mode used to measure aortic di-
mensions (intimal area, medial thickness, or elastin frag-
mentation), no signiﬁcant differences in aortic expansionwere
detected between Ang IIeinfused WT or Ldlr/ mice.
Because hypercholesterolemia did not affect ascending
aortic dilation, male WT mice fed a normal laboratory diet
were used to determine the role of blood pressure. Mice
were infused for 28 days with 5.6 mg/kg NE per day, 1000
ng/kg Ang II per minute, or saline. Ang II and NE infusion
equivalently increased systolic blood pressure, compared
with saline infusion (167  4 and 164  1 mmHg,
respectively, versus 148  3 mmHg; P < 0.05) (Figure 3A).
As expected, Ang II infusion signiﬁcantly increased aortic
arch intimal area, compared with saline infusion (14.1  0.4
versus 10.8  0.4 mm2; P < 0.001) (Figure 3B). Although2590NE infusion increased systolic blood pressure, the aortic
arch did not expand signiﬁcantly, compared with the saline
group (10.6  0.3 mm2 versus 10.8  0.4 mm2, respec-
tively; P Z 0.673).
Intramural Hematoma and Focal Intimal Tearing of the
Ascending Aorta Occurs during Ang II Infusion
Pathological changes in arterial tissue were associated with
dilation and expansion of the ascending aorta. When
compared to saline-infused tissue (Figure 4A), intramural
hematoma was visible throughout the ascending aorta and
extending to the carotid branch of the aortic arch at day 5 of
Ang II infusion (Figure 4B) at an incidence of 12.5%. Red
blood cell extravasation was observed on the anterior
portion of the ascending aorta from Ang IIeinfused mice
(Figure 4C), in the outer lamellar units (Figure 4, D and E).
Although the distances between elastin laminae on the
luminal aspect were normal, distances between lamellar
units on the adventitial aspects of the aorta were increased
because of hemorrhage (Figure 4, F and G). a-Actinþajp.amjpathol.org - The American Journal of Pathology
Figure 5 Limited tearing or incomplete rupture of the intimalemedial
region of the ascending aorta continues during Ang II infusion. A:
Representative longitudinal cross section reveals a focal intimalemedial
incomplete tear on the anterior wall of an ascending aorta. Boxed regions
in the main image are shown in detail in the corresponding enlargements of
anterior tear (blue box), proximal aorta with intralamellar hemorrhage
(orange box), and unaffected posterior aortic wall (green box). BeD:
Representative images of ascending aorta cross sections retrieved after 28
days of Ang II infusion and stained with hematoxylin and eosin (B),
stained with Movat’s pentachrome (C), and immunostained for smooth
muscle a-actin (D) (red). Disrupted media are indicated by arrows. In A,
lumen is indicated by an L; in BeD, images are oriented with lumen at top.
Figure 6 Adventitial leukocyte accumulation occurred in the aorta of
male C57BL/6J mice during chronic Ang II infusion. A, C, and E: A CD45
antibody was used to detect leukocytes (red) before (A) and after 5 days
(C) or 28 days (E) of Ang II infusion. B, D, and F: A reticular ﬁbroblast
antibody (ER-TR7) was used to detect ﬁbroblasts (red) before (B) and after
5 days (D) or 28 days (F) of Ang II infusion. Sections were counterstained
with hematoxylin; images are oriented with lumen at top.
Ang II and Ascending Aortic Aneurysmsmooth muscle cells were detected only in inner laminar
layers (Figure 4, H and I). We were unable to detect an entry
point of blood into the outer intralamellar units of the media.
This pathology was not seen in any of the aortas harvested
after day 15 of Ang II infusion. However, residues of
hemorrhage, as deﬁned by Prussian Blue staining, were
present only in the adventitial and outer medial layers of
Ang IIeinfused aortas (Supplemental Figure S5).
Although intramural hematoma was an occasional early
event during Ang II infusion, limited tearing or incomplete
medial rupture was frequently present after more protracted
infusion (Figure 5). After 28 days of Ang II infusion, this
occurred in 9/15 (56%) mice. The site of partial medial
break was on the inner lateral surface of the ascending
aorta. Unlike the prevalent location of hematoma in the
outer lamellar layers of the aorta, partial medial breaks
occurred on the anterior aspect in the inner lamellar units
(Figure 5A). At this site, medial thickness was decreased
because elastin breakage reduced the inner lamellar layers
(Figure 5, BeD). The extent of elastin degradation differed
around the circumference of the aorta, with extensive
elastin breaks present in the anterior medial region and
minimal changes in integrity in the posterior medial region
of the aorta (Figure 5A). Of the 48 experimental mice, 3
mice died (6% incidence) during 2 to 5 days of Ang II
infusion, because of rupture of either the thoracic (n Z 2)
or abdominal (n Z 1) aorta.The American Journal of Pathology - ajp.amjpathol.orgTo determine the presence of leukocytes, aortic tissues
were immunostained for CD45, the common leukocyte an-
tigen. CD45þ leukocytes were present only sparsely in the
aortic adventitia after 28 days of Ang II infusion (Figure 6,
A, C, and E). Most of the cells located in the adventitia
stained positive for the ﬁbroblast marker ER-TR7 (Figure 6,
B, D, and F).Loss of Outer Medial Smooth Muscle Cells, Elastin
Fragmentation, and Adventitial Inﬂammation Occurs
in Human Thoracic AA Tissue
The BAV Study (NCT01202721; http://www.clinicaltrials.
gov) is an ongoing clinical trial to determine effects of
AT1 receptor antagonism on ascending aortic dilation in
patients with bicuspid aortic valves. To determine whether
pathological aspects of Ang IIeinduced ascending AAs in
mice recapitulates human disease, we examined aortic tissue
retrieved during surgical repair of patients with bicuspid
aortic valves. Loss of smooth muscle markers in outer
lamellar units occurred in sections of human ascending
aortic tissue, as illustrated by a gradient of immunostaining
for a-actin (Figure 7A). Elastin fragmentation was visible
throughout the aortic media (Figure 7B). CD45þ leukocytes2591
Rateri et alwere detected in the adventitia, but were absent in the aortic
media (Figure 7C). Movat’s pentachrome staining demon-
strated a gradient of changes from the lumen to the adven-
titial aspect, with increasing presence of proteoglycans at
the outer margins (Figure 7D).
Discussion
Although ascending AAs may be generated via several
pathways, there is evolving evidence that Ang II has a major
role.2,11 For example, a recent clinical trial demonstrated that
the AT1 receptor antagonist losartan decreased aortic root
dilation in adults with Marfan syndrome.19 Several other
studies are ongoing to determine the effects of AT1 receptor
antagonism on aortic dilation in children with Marfan
syndrome and adults with biscupid aortic valves (http://
www.clinicaltrials.gov, NCT00763893, NCT01949233,
ISRCTN90011794, NCT01202721).11 Also, ascending
aortic dilation in several mousemodels is attenuated byAT1
receptor antagonism.3,4,20 Here, we used a model in which
ascending AAs were generated reproducibly by chronic
subcutaneous Ang II infusion. This model was initially re-
ported in hypercholesterolemic mice,7 but in the present
study we demonstrated that disease progressed in an indis-
tinguishable manner in normocholesterolemic mice. Further-
more, the systolic blood pressureeelevating effects of Ang II
are not responsible for the initiation and development of
ascending AAs. We also examined the evolving aneurysmal
pathology during Ang II infusion and noted similarities to the
human disease.Figure 7 Loss of smooth muscle cells, elastin fragmentation, and
presence of adventitial inﬂammation was observed in cross sections of
ascending AAs resected from patients with bicuspid aortic valve disease. A:
Bicuspid aortic valve samples immunostained for a-actin to detect smooth
muscle cells (red). B: Elastin was detected with Verhoeff’s stain; elastin
breaks are indicated by red arrows. C: Leukocytes were detected with a
CD45 antibody (red). D: Muscle and collagen were detected with Movat’s
pentachrome stain. Images are oriented with lumen at top.
2592The high-frequency ultrasound instruments currently in
use have a range of features, including acquisition of high-
resolution images using multiple focal lengths. This feature
accurately and noninvasively measures ascending aortic
expansion during Ang II infusion. Noninvasive ultrasound
imaging also allows for calculation of biomechanical forces
acting on the aortic wall, which in abdominal AAs have been
suggested as a parameter for determining risk of aortic
rupture.21 In the present study, ascending aortic expansion
was associated with an increase in vessel stiffness and a
decrease in circumferential cyclic strain. These changes in
biomechanical parameters during Ang II infusion are in
agreement with previous ex vivo studies on human ascending
thoracic AA tissue obtained at the time of surgery.22,23
Development of Ang IIeinduced ascending AAs in mice
was recognized initially by the gross appearance of the dilated
ascending aorta and overt thickening of the aortic arch region.7
That initial study used two different measurements of diam-
eter, calculated from perimeter and intimal surface area, to
provide a quantitative index of aneurysm severity.7,24,25 A
shortcoming of the area measurement was inclusion of a large
area of the descending aorta that is not dilated by Ang II
infusion. We therefore modiﬁed this analysis to restrict mea-
surement to the intimal surface of the ascending and aortic arch
regions, where this overt pathology is most prevalent. In
accord with previous measurements of the proximal thoracic
aorta, Ang II promoted a rapid and pronounced dilation in the
more restricted aortic region during 28 days of Ang II infusion.
Studies by several research groups have demonstrated
that short-term hypercholesterolemia greatly increased the
incidence of Ang IIeinduced abdominal AAs,15,26,27
although this relationship has not been described previ-
ously for Ang IIeinduced ascending AAs. The initial study
that described Ang IIeinduced ascending AAs was per-
formed in grossly hypercholesterolemic mice.7 In the pre-
sent study, we directly compared Ang IIeinduced ascending
AA development in normo- and hypercholesterolemic mice
and demonstrated an equivalency of dilation. The role of
hypercholesterolemia in development of thoracic AAs in
humans is unclear. Recent guidelines recommend stringent
optimization of lipid proﬁles, with inclusion of statin
therapy.12 However, this recommendation is related to the
potential beneﬁt of reducing the atherosclerosis that may
exist in individuals with ascending AAs, rather than to any
direct effect upon aortic dilation. Although we were unable
to demonstrate an effect of hypercholesterolemia on this
Ang IIeinduced pathology in mice, it will be important to
deﬁne effects of aberrant lipoprotein metabolism in the
development of ascending AAs.
There is a common association of increased blood pres-
sure with cardiovascular diseases; however, it is unclear
whether aortic dilation is augmented by increased blood
pressure per se. Previous studies have demonstrated that
Ang II induction of atherosclerosis and abdominal AAs is
unrelated to increased systolic blood pressure, because
equivalent hypertension during NE infusion had no effect onajp.amjpathol.org - The American Journal of Pathology
Ang II and Ascending Aortic Aneurysmthese diseases.28,29 With the same approach in C57BL/6J
mice, infusion of NE induced similar increases in blood
pressure to Ang II, but failed to have any effect on aortic
dimensions and did not cause detectable pathology in the
thoracic aorta.
Initiation of Ang IIeinduced ascending AAs was rapid,
with changes in aortic dimensions and medial pathology
readily apparent after only 5 days of infusion. We have
previously demonstrated that Ang II infusion promotes
ascending aortic pathology through stimulation of AT1a
receptors, with no discernible effect on AT1b receptors.13,30
Surprisingly, smooth muscle cellespeciﬁc deletion of AT1a
receptors had no effect on Ang IIeinduced ascending AAs.9
Genetic depletion of endothelial AT1a receptor reduced
development of Ang IIeinduced ascending AAs, although
the effect was only a partial attenuation.9 In some mice, this
early phase was also associated with presence of blood
accumulating in outer laminal layers of the media, with a
distinctive distribution on the anterior portion of the
ascending aorta. We had initially hypothesized that blood
entered the media at the interface of smooth muscle cells
derived from the second heart ﬁeld, as opposed to the car-
diac neural crest.31 However, we were unable to determine a
route of entry for blood into the media of the aortic root.
Curiously, we did not observe any mice with intralaminal
hemorrhage at later stages of Ang II infusion and inferred
that this intramedial blood had resolved. Notably, hemor-
rhage resolution was not associated with an inﬂammatory
response as deﬁned by accumulation of leukocytes. How-
ever, there was an accumulation of CD45þ cells in the
adventitia of ascending AAs. There was also marked frag-
mentation of elastin that localized to the anterior aspect of
this region of the aorta. These features of elastin fragmen-
tation and adventitial CD45 accumulation had similarities to
surgically acquired ascending AA samples from patients
with bicuspid aortic valve disease. Therefore, although
aortic samples cannot be acquired on a temporal basis from
humans, in its later stages the Ang II induction of this dis-
ease in mice had striking resemblance to human pathology.
Chronic Ang II infusion into mice promotes development of
aneurysms in both ascending and suprarenal regions of the
aorta.15,32 However, beyond the regional differences, many
characteristics differ between ascending and suprarenal
AAs.33,34 In the present study, hypercholesterolemia had no
discernible effect on development of ascending AAs, with an
identical expansion rate for C57BL/6J and Ldlr/ mice. By
contrast, the incidence of Ang IIeinduced abdominal AA
development in normocholesterolemic mice was is markedly
lower than in hypercholesterolemic mice. Further, Ang IIe
induced abdominal AAs had a region of marked focal lumen
expansion surrounded by proximal and distal regions of intact
media encased in thickened adventitia. For Ang IIeinduced
ascending AAs, there was consistent lumen expansion
throughout the ascending aorta, with minimal adventitial
thickening. Finally, there were major differences in the his-
tological characteristics of the tissue. In Ang IIeinducedThe American Journal of Pathology - ajp.amjpathol.orgabdominal AAs, there was a focal transmural elastin break,
with minor changes in the elastin integrity of the rest of the
media. This focal aortic rupture led to thrombus accumu-
lation in the adventitia. These characteristics contrast the
diffuse elastin degradation and a gradient of medial changes
in Ang IIeinduced ascending AAs. The basis for pro-
foundly differing responses to Ang II in ascending versus
suprarenal aortic regions are undeﬁned, but may involve
differences in embryonic origins of intimal, medial, and
adventitial cells in these two regions.35,36 It would be of
interest if later studies determine whether mechanisms that
inﬂuence abdominal AA development have equivalent or
disparate effects on ascending AAs.37e39
Ang II induces ascending AAs through stimulation of
AT1a receptors.9 Although whole-body deletion of AT1a
receptors ablates Ang IIeinduced ascending AAs, deletion
of AT1a receptors in endothelium modestly reduces disease,
but deletion in smooth muscle has no effect.9 Thus, the
major cell type stimulated by Ang II to promote ascending
AAs is undeﬁned. Recent studies have focused on the role
of adventitial ﬁbroblasts in experimental AA develop-
ment,6,40,41 and it would be of interest to examine the role of
ﬁbroblast-speciﬁc deletion of AT1a receptors on the pa-
thology we have described here.
In conclusion, we have demonstrated that hypercholes-
terolemia and blood pressure are not signiﬁcant modiﬁers of
Ang IIeinduced ascending AAs in mice. We also demon-
strated that aneurysms in the ascending aortic region are a
consequence of a series of changes that are associated with
profound lumen expansion and complex medial changes.
Furthermore, several pathological features of Ang IIe
induced ascending AAs in mice are represented in the
human disease. Knowledge of the temporal basis of vascular
pathology should facilitate interpretation of future mecha-
nistic studies.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2014.05.014.
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